# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-26-191603
Filing Date
2026-04-29
Accepted
2026-04-29 16:13:23
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ars_4.29.26.pdf | ARS | 847600
| Complete submission text file | 0001193125-26-191603.txt |  | 1168794

Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39527 | Film No.: 26916184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)